MYGN

Myriad wins European patent appeal on cancer test - 11/20 - 11:53 AM ET

Myriad Genetics 2008 - A Retrospective - 11/12 - 04:27 AM ET

Myriad Genetics Finished Wednesday at Second Consecutive New High For year - 11/06 - 08:07 AM ET

Myriad has first profitable quarter - 11/05 - 07:01 AM ET

MYGN hits 52-week high at 71.40 - 11/05 - 10:39 AM ET

SmarTrend(R) UPTREND Alert: Myriad Genetics (NASDAQ:MYGN) - 11/04 - 05:07 PM ET

Market Review: Our Progressive Review of MYGN - 11/04 - 08:49 AM ET

MYGN: Q1 Earnings Call @ 10:00 ET Today [delayed] - 11/04 - 07:29 AM ET

UPDATE 1-Myriad Genetics Q1 profit beats Street - 11/04 - 07:19 AM ET

BRIEF-Myriad Genetics reports Q1 results - 11/04 - 06:34 AM ET

Myriad Genetics, Inc. Reports Results for First Quarter of Fiscal 2009 - 11/04 - 06:30 AM ET

Melbourne-based company seeks sole rights - 10/23 - 01:34 PM ET

Myriad Genetics Announces First Quarter Fiscal 2009 Financial Results Conference Call - 10/23 - 11:52 AM ET

Research park moves ahead: Cutting-edge facility could help create work force housing at Kimball Junction - 10/22 - 11:07 AM ET

Myriad Genetics (MYGN) NewsBite - MYGN Jumps on Spinoff Announcement - 10/21 - 02:46 PM ET

Myriad Genetics to spin off drug development business - 10/21 - 09:14 AM ET

MYGN: Conference call regarding Announces Plan to Separate Into Two Independent Public Companies @ 13:00 ET Today [delayed] - 10/21 - 01:27 AM ET

Myriad Genetics to spin off drug development business from molecular diagnostics business - update - 10/20 - 07:13 PM ET

Myriad Genetics Announces Plan to Separate Into Two Independent Public Companies - 10/20 - 05:45 PM ET

Myriad Genetics Inc announces acquisition of novel therapeutic drug management technology - 10/08 - 08:04 AM ET

Page 1 of 6     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index